IRIS
PUGLISI, Fabio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.179
AS - Asia 9.280
EU - Europa 5.560
SA - Sud America 1.876
AF - Africa 177
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 11
Totale 38.106
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.901
SG - Singapore 4.656
CN - Cina 1.828
BR - Brasile 1.577
UA - Ucraina 1.265
HK - Hong Kong 1.075
DE - Germania 875
IT - Italia 839
VN - Vietnam 727
RU - Federazione Russa 577
FI - Finlandia 455
SE - Svezia 350
IE - Irlanda 312
GB - Regno Unito 275
IN - India 253
TR - Turchia 171
CA - Canada 160
KR - Corea 143
AR - Argentina 114
FR - Francia 96
PL - Polonia 78
AT - Austria 77
NL - Olanda 70
BD - Bangladesh 67
MX - Messico 65
JP - Giappone 57
BE - Belgio 53
ZA - Sudafrica 52
EC - Ecuador 50
ID - Indonesia 49
CZ - Repubblica Ceca 42
CO - Colombia 38
ES - Italia 38
CH - Svizzera 36
IQ - Iraq 33
TG - Togo 30
IR - Iran 29
RO - Romania 28
AE - Emirati Arabi Uniti 23
MA - Marocco 23
PK - Pakistan 23
PY - Paraguay 23
VE - Venezuela 23
LT - Lituania 19
EU - Europa 16
CL - Cile 15
PE - Perù 15
SA - Arabia Saudita 15
UY - Uruguay 15
TN - Tunisia 14
UZ - Uzbekistan 14
DZ - Algeria 13
EG - Egitto 13
GR - Grecia 11
IL - Israele 11
KZ - Kazakistan 10
AU - Australia 9
AZ - Azerbaigian 9
NP - Nepal 9
AM - Armenia 8
EE - Estonia 8
JM - Giamaica 8
LV - Lettonia 8
BG - Bulgaria 7
DO - Repubblica Dominicana 7
KG - Kirghizistan 7
AL - Albania 6
BO - Bolivia 6
OM - Oman 6
TH - Thailandia 6
BY - Bielorussia 5
CR - Costa Rica 5
KE - Kenya 5
LA - Repubblica Popolare Democratica del Laos 5
LB - Libano 5
PS - Palestinian Territory 5
RS - Serbia 5
TT - Trinidad e Tobago 5
BB - Barbados 4
JO - Giordania 4
MD - Moldavia 4
NO - Norvegia 4
PA - Panama 4
BH - Bahrain 3
CI - Costa d'Avorio 3
CW - ???statistics.table.value.countryCode.CW??? 3
DK - Danimarca 3
GT - Guatemala 3
HN - Honduras 3
HR - Croazia 3
KH - Cambogia 3
LK - Sri Lanka 3
NI - Nicaragua 3
SN - Senegal 3
SV - El Salvador 3
TW - Taiwan 3
XK - ???statistics.table.value.countryCode.XK??? 3
BA - Bosnia-Erzegovina 2
CY - Cipro 2
GE - Georgia 2
Totale 38.049
Salva come PNG Salva come JPEG
Città #
Fairfield 2.560
Ashburn 2.009
Woodbridge 1.761
Singapore 1.730
Houston 1.278
Chandler 1.120
Hong Kong 1.074
Ann Arbor 1.010
Seattle 1.008
Wilmington 930
Beijing 894
Cambridge 854
Jacksonville 812
Dearborn 547
Los Angeles 473
Boardman 453
Chicago 425
Dublin 305
Princeton 298
New York 225
Ho Chi Minh City 224
Buffalo 191
Udine 191
Hefei 186
Dallas 179
Salt Lake City 172
Munich 156
Dong Ket 145
São Paulo 144
San Diego 142
Redondo Beach 136
Seoul 133
Hanoi 129
Izmir 125
Elk Grove Village 94
Tampa 87
Des Moines 84
Ogden 84
Nuremberg 72
Warsaw 67
Santa Clara 57
Ottawa 53
Tokyo 53
Norwalk 50
Brussels 49
Lancaster 49
Denver 48
Montreal 48
Turku 47
Brooklyn 46
Guangzhou 46
Phoenix 46
Nanjing 45
Sterling 44
London 43
Helsinki 42
Miami 42
Mumbai 42
Stockholm 41
Kunming 40
Frankfurt am Main 38
Belo Horizonte 37
Rio de Janeiro 37
Washington 37
Codroipo 36
Poplar 36
Lappeenranta 34
Milan 34
Chennai 33
Orem 32
Trieste 32
Johannesburg 31
Lomé 30
Mexico City 30
Vienna 30
Brno 29
Redmond 29
Toronto 27
Brasília 26
Curitiba 26
Düsseldorf 26
Falls Church 26
Martignacco 26
Zurich 26
Amsterdam 25
Boston 25
Jinan 25
Atlanta 24
Dulles 24
San Francisco 24
Venice 24
Da Nang 23
Detroit 23
Hyderabad 23
Porto Alegre 22
Rome 22
Biên Hòa 21
Campinas 21
Augusta 20
Lauterbourg 20
Totale 24.552
Salva come PNG Salva come JPEG
Nome #
Risks in Oncology and Radiation Therapy 676
Characterizing metastatic HER2-positive gastric cancer at the CDH1 haplotype 664
Extended Adjuvant Endocrine Treatment in Luminal Breast Cancers in the Era of Genomic Tests 463
Hepatitis B and cancer: A practical guide for the oncologist 230
Bone scanning in lung cancer [2] (multiple letters) 217
In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis 203
BNC2 is a putative tumor suppressor gene in high-grade serous ovarian carcinoma and impacts cell survival after oxidative stress 203
The SLICE study: The prognostic role of visceral fat in metastatic colorectal cancer 195
Role of pre-surgical breast MRI in the management of invasive breast carcinoma 191
Adjuvant endocrine therapy in postmenopausal breast cancer patients: does hormone receptor status influence decision-making? 191
First steps in the definition of a prognostic score based on MGMT methylation status in patients with glioblastoma 181
Acetylation on critical lysine residues of Apurinic/apyrimidinic endonuclease 1 (APE1) in triple negative breast cancers 179
MGMT pyrosequencing-based cut-off methylation level and clinical outcome in patients with glioblastoma multiforme 176
Luminal-like HER2-negative stage IA breast cancer: A multicenter retrospective study on long-term outcome with propensity score analysis 174
Expression of periostin in human breast cancer 172
Neutrophil-to-lymphocyte and lymphocyte-to-monocyte ratios in breast cancer 168
Bevacizumab in older patients with advanced colorectal or breast cancer 166
Role of mammography, ultrasound and large-core biopsy in the diagnostic evaluation of papillary breast lesions 166
Epigenetic bivalent marking is permissive to the synergy of HDAC and PARP inhibitors on TXNIP expression in breast cancer cells 164
Bone scanning in lung cancer: pretest probability is of value 163
D-dimer and venous thromboembolism 162
B-cell lymphoma presenting as acute pancreatitis 161
Galectin-3 expression in non-small cell lung carcinoma 161
Pattern of metastasis and outcome in patients with breast cancer 161
Gene expression profiling in breast cancer: a clinical perspective. 160
BRCA2 GERMLINE MUTATIONS IN PRIMARY CANCER OF THE FALLOPIAN TUBE 160
Molecular diagnosis of neoplasms 159
Androgen receptor in estrogen receptor positive breast cancer: Beyond expression 159
Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials. 158
The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients 158
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype 158
Defining a prognostic score based on O6-methylguanine-DNA methyltransferase cut-off methylation level determined by pyrosequencing in patients with glioblastoma multiforme 158
Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a "standard chemotherapy regimen": the CASA randomized trial. 155
What does similarity mean in clinical trials? 154
Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for A Cost-Effective and Dynamic Biomarker 153
Primary therapy in breast cancer: what have we learned from landmark trials? 152
Adjuvant exemestane with ovarian suppression in premenopausal breast cancer 151
Skeletal metastases from breast cancer: pathogenesis of bone tropism and treatment strategy 151
Impact of hepatitis C virus infection on clinical features, quality of life and survival of patients with lymphoplasmacytoid lymphoma/immunocytoma 150
A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study 150
Taxane-induced nail changes: incidence, clinical presentation and outcome 149
Sonographic criteria for differentiation of benign and malignant solid breast lesions: size is of value 149
Measures of outcome in metastatic breast cancer: insights from a real-world scenario. 149
Caring for cancer survivors: perspectives of oncologists, general practitioners and patients in Italy 148
Prognostic role of disease extent and lymphocyte-monocyte ratio in advanced melanoma 148
Trastuzumab and breast cancer. Are we just beyond the prologue of a fascinating story? 146
Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside 145
Treatment of metastatic breast cancer in a real-world scenario: Is progression-free survival with first line predictive of benefit from second and later lines? 143
APE1 and NPM1 protect cancer cells from platinum compounds cytotoxicity and their expression pattern has a prognostic value in TNBC 143
Correlation between variation in quality of life and change in hemoglobin level after treatment with epoetin alfa 40,000 IU administered once-weekly 143
Immunocytochemical expression of tissue specific transcription factor-1 in lung carcinoma 142
Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studies 142
Angiogenesis and tumor growth 141
TSH controls ref-1 nuclear translocation in thyroid cells 141
Comparison of primary breast cancer and paired metastases: biomarkers discordance influence on outcome and therapy 140
Prognostic evaluation in palliative care: final results from a prospective cohort study 140
Real-time tests of multiple genome alterations take the first steps into the clinic: a learning example 139
Predictors of axillary lymph node metastases in patients with T1 breast carcinoma 139
p53 protein expression and p53 mutation in thymic epithelial tumors 138
Hot topics and landmark studies from the 43rd annual meeting of the American Society of Clinical Oncology 138
Vaccination for seasonal influenza in patients with cancer: Recommendations of the Italian Society of Medical Oncology (AIOM) 138
Circulating tumor DNA analysis in breast cancer: Is it ready for prime-time? 138
CDK 4/6 inhibitors as single agent in advanced solid tumors 136
Patterns of care and clinical outcomes of first-line trastuzumab-based therapy in HER2-positive metastatic breast cancer patients relapsing after (Neo)adjuvant trastuzumab: An Italian multicenter retrospective cohort study 136
A multicentre Phase II study of non-pegylated liposomal doxorubicin in combination with trastuzumab and docetaxel as first-line therapy in metastatic breast cancer 135
Looking for predictive markers in breast cancer 135
Evidence-based appraisal of the upfront treatment for unresectable metastatic colorectal cancer patients 135
A Delphi consensus and open debate on the role of first-line bevacizumab for HER2-negative metastatic breast cancer 134
Capecitabine-induced cardiotoxicity: More evidence or clinical approaches to protect the patients' heart? 134
LOCALLY ADVANCED BREAST CANCER: COMPARISON OF MAMMOGRAPHY, SONOGRAPHY AND MR IMAGING IN EVALUATION OF RESIDUAL DISEASE IN WOMEN RECEIVING NEOADJUVANT CHEMOTHERAPY 134
The role of sidedness in second-line therapy for RAS wild-type colorectal cancer: a network meta-analysis (NMA) 133
PROTEOMIC EVALUATION OF CORE BIOPSY SPECIMENS FROM BREAST LESIONS 132
Expression and localization of the homeodomain-containing protein HEX in human thyroid tumors 132
Adjuvant endocrine therapy in premenopausal patients with hormone receptor-positive early breast cancer: Evidence evaluation and GRADE recommendations by the Italian Association of Medical Oncology (AIOM) 132
A risk score integrating lymphocytes ratios (LRs) and lactate dehydrogenase (LDH) levels to predict prognosis in metastatic breast cancer (MBC) patients 132
First-line chemotherapy with or without biologic agents for metastatic breast cancer 131
Hormone therapy in elderly breast cancer patients with comorbidities 131
Cognitive functions and elderly cancer patients receiving anticancer treatment: a prospective study 131
Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial 131
Body mass index and circulating oestrone sulphate in women treated with adjuvant letrozole 131
Endocrine therapy in premenopausal women with breast cancer: a critical appraisal of current evidence 131
Effect of age on hemoglobin levels and quality of life following treatment with epoetin alfa in cancer patients 130
Observational study on adjuvant trastuzumab in HER2-positive early breast cancer patients 130
From the podium to the patient: Bringing the 2008 ASCO meeting to the clinic 129
Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Cutaneous Melanoma 129
Expert pathology consultation through the Internet: melanoma versus benign melanocytic tumours 128
Large core biopsy for diagnostic and prognostic evaluation of invasive breast carcinomas 128
Information to cancer patients: a questionnaire survey in three different geographical areas in Italy. 128
Thymidine phosphorylase expression in metastatic kidney cancer as a potential predictor of outcome in patients treated with sunitinib 128
Controversies in monitoring metastatic breast cancer during systemic treatment. Results of a GIM (Gruppo Italiano Mammella) survey 128
Do platinum salts fit all triple negative breast cancers? 128
Treatment of HER2-positive breast cancer: current status and future perspectives 127
MR mammography using diffusion-weighted imaging in evaluating breast cancer: a correlation with proliferation index 127
Human epidermal growth factor receptor 2 dual blockade with trastuzumab and pertuzumab in real life: Italian clinical practice versus the CLEOPATRA trial results 127
Prognostic role of disease extent and lymphocyte-monocyte ratio in advanced melanoma 126
Plasma estrone sulfate concentrations and genetic variation at the CYP19A1 locus in postmenopausal women with early breast cancer treated with letrozole 125
FEASIBILITY STUDY OF A WEB APPLICATION FOR SELF-REPORT OF ANTICANCER TREATMENT TOXICITIES 125
Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): A combined analysis of two phase 3 randomised trials 125
Balance between cell division and cell death as predictor of survival in patients with non-small-cell lung cancer 125
Dramatic tumour response to pemetrexed single-agent in an elderly patient with malignant peritoneal mesothelioma: a case report 124
Totale 16.155
Salva come PNG Salva come JPEG
Categoria #
all - tutte 153.278
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 153.278
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.395 0 0 0 0 0 389 225 435 416 168 419 343
2021/20222.555 214 216 83 162 69 142 148 116 40 440 551 374
2022/20232.662 332 191 71 309 270 726 29 205 338 37 90 64
2023/20241.387 123 91 73 51 194 277 41 74 134 109 59 161
2024/20257.555 190 466 304 251 377 416 470 430 768 706 1.191 1.986
2025/20269.615 1.641 2.326 1.454 1.607 2.241 346 0 0 0 0 0 0
Totale 39.333